Foulkes WD - Search Results

1

SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors.

Shorstova T, Marques M, Su J, Johnston J, Kleinman CL, Hamel N, Huang S, Alaoui-Jamali MA, Foulkes WD, Witcher M. Shorstova T, et al. Among authors: foulkes wd. Cancer Res. 2019 May 15;79(10):2761-2774. doi: 10.1158/0008-5472.CAN-18-1545. Epub 2019 Mar 15. Cancer Res. 2019. PMID: 30877105

2

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S. Warner E, et al. J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7. doi: 10.1093/jnci/91.14.1241. J Natl Cancer Inst. 1999. PMID: 10413426

3

An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck.

Hamel N, Manning A, Black MJ, Tonin PN, Foulkes WD. Hamel N, et al. Among authors: foulkes wd. Int J Cancer. 1999 Dec 10;83(6):803-4. doi: 10.1002/(sici)1097-0215(19991210)83:6<803::aid-ijc17>3.0.co;2-n. Int J Cancer. 1999. PMID: 10597198 Free article. No abstract available.

4

No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck.

Hamel N, Black MJ, Ghadirian P, Foulkes WD. Hamel N, et al. Among authors: foulkes wd. Br J Cancer. 2000 Feb;82(4):757-9. doi: 10.1054/bjoc.1999.0993. Br J Cancer. 2000. PMID: 10732740 Free PMC article.

5

Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.

Liu G, Ghadirian P, Vesprini D, Hamel N, Paradis AJ, Lal G, Gallinger S, Narod SA, Foulkes WD. Liu G, et al. Among authors: foulkes wd. Br J Cancer. 2000 May;82(10):1646-9. doi: 10.1054/bjoc.2000.1221. Br J Cancer. 2000. PMID: 10817498 Free PMC article.

6

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD. Greenblatt MS, et al. Among authors: foulkes wd. Cancer Res. 2001 May 15;61(10):4092-7. Cancer Res. 2001. PMID: 11358831

7

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.

Chappuis PO, Hamel N, Paradis AJ, Deschênes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD. Chappuis PO, et al. Among authors: foulkes wd. Clin Genet. 2001 Jun;59(6):418-23. doi: 10.1034/j.1399-0004.2001.590606.x. Clin Genet. 2001. PMID: 11453973

8

Risk assessment & genetic testing.

Chappuis PO, Foulkes WD. Chappuis PO, et al. Among authors: foulkes wd. Cancer Treat Res. 2002;107:29-59. doi: 10.1007/978-1-4757-3587-1_2. Cancer Treat Res. 2002. PMID: 11775456 Review.

9

Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells.

Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD. Al Moustafa AE, et al. Among authors: foulkes wd. Oncogene. 2002 Apr 18;21(17):2634-40. doi: 10.1038/sj.onc.1205351. Oncogene. 2002. PMID: 11965536

10

Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins.

Ah Mew N, Hamel N, Galvez M, Al-Saffar M, Foulkes WD. Ah Mew N, et al. Among authors: foulkes wd. Clin Genet. 2002 Aug;62(2):151-6. doi: 10.1034/j.1399-0004.2002.620208.x. Clin Genet. 2002. PMID: 12220453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

736 results

Search Page